Pazaitou-Panayiotou K - Search Results

1

Management of pediatric papillary thyroid cancer.

Pazaitou-Panayiotou K. Pazaitou-Panayiotou K. Hell J Nucl Med. 2023 May-Aug;26 Suppl:60-64. Hell J Nucl Med. 2023. PMID: 37658567 Free article.

2

99mTc pertechnetate thyroid scan leads to serendipitous detection of metastatic thyroid cancer.

Mathiopoulou L, Chrisoulidou A, Boudina M, Mitsakis P, Mandanas S, Pazaitou-Panayiotou K. Mathiopoulou L, et al. Clin Nucl Med. 2012 Jun;37(6):604-6. doi: 10.1097/RLU.0b013e31824c77c9. Clin Nucl Med. 2012. PMID: 22614199

3

Histological subtype is the most important determinant of survival in metastatic papillary thyroid cancer.

Chrisoulidou A, Boudina M, Tzemailas A, Doumala E, Iliadou PK, Patakiouta F, Pazaitou-Panayiotou K. Chrisoulidou A, et al. Thyroid Res. 2011 Jul 19;4(1):12. doi: 10.1186/1756-6614-4-12. Thyroid Res. 2011. PMID: 21771294 Free PMC article.

4

The increase in thyroid cancer incidence is not only due to papillary microcarcinomas: a 40-year study in 1 778 patients.

Pazaitou-Panayiotou K, Iliadou PK, Chrisoulidou A, Mitsakis P, Doumala E, Fotareli A, Boudina M, Mathiopoulou L, Patakiouta F, Tziomalos K. Pazaitou-Panayiotou K, et al. Exp Clin Endocrinol Diabetes. 2013 Jul;121(7):397-401. doi: 10.1055/s-0033-1345125. Epub 2013 May 21. Exp Clin Endocrinol Diabetes. 2013. PMID: 23696480 Clinical Trial.

5

Vitamin D receptor and progesterone receptor protein and gene expression in papillary thyroid carcinomas: associations with histological features.

Yavropoulou MP, Panagiotou G, Topouridou K, Karayannopoulou G, Koletsa T, Zarampoukas T, Goropoulos A, Chatzaki E, Yovos JG, Pazaitou-Panayiotou K. Yavropoulou MP, et al. J Endocrinol Invest. 2017 Dec;40(12):1327-1335. doi: 10.1007/s40618-017-0700-4. Epub 2017 Jun 6. J Endocrinol Invest. 2017. PMID: 28589382

6

The Immunocytochemistry Is a Valuable Tool in the Diagnosis of Papillary Thyroid Cancer in FNA's Using Liquid-Based Cytology.

Pazaitou-Panayiotou K, Mygdakos N, Boglou K, Kiziridou A, Chrisoulidou A, Destouni C. Pazaitou-Panayiotou K, et al. J Oncol. 2010;2010:963926. doi: 10.1155/2010/963926. Epub 2010 Oct 27. J Oncol. 2010. PMID: 21052476 Free PMC article.

7

Cerebellar metastasis as first metastasis from papillary thyroid carcinoma.

Pazaitou-Panayiotou K, Kaprara A, Chrisoulidou A, Boudina M, Georgiou E, Patakiouta F, Drimonitis A, Vainas I. Pazaitou-Panayiotou K, et al. Endocr J. 2005 Dec;52(6):653-7. doi: 10.1507/endocrj.52.653. Endocr J. 2005. PMID: 16410655 Free article.

8

Thyroid cancer in patients with hyperthyroidism.

Pazaitou-Panayiotou K, Michalakis K, Paschke R. Pazaitou-Panayiotou K, et al. Horm Metab Res. 2012 Apr;44(4):255-62. doi: 10.1055/s-0031-1299741. Epub 2012 Feb 14. Horm Metab Res. 2012. PMID: 22334393 Review.

9

Papillary thyroid carcinomas in patients under 21 years of age: clinical and histologic characteristics of tumors ≤10 mm.

Pazaitou-Panayiotou K, Iliadou PK, Mandanas S, Vasileiadis T, Mitsakis P, Tziomalos K, Alevizaki M, Patakiouta F. Pazaitou-Panayiotou K, et al. J Pediatr. 2015 Feb;166(2):451-6.e2. doi: 10.1016/j.jpeds.2014.10.023. Epub 2014 Nov 18. J Pediatr. 2015. PMID: 25453245

10

Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans.

Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, Mantzoros CS. Panagiotou G, et al. Among authors: pazaitou panayiotou k. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2137-e2150. doi: 10.1210/clinem/dgab041. J Clin Endocrinol Metab. 2021. PMID: 33493282

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

67 results

Search Page